Management of an unintentional enoxaparin overdose: A case report and literature review

Abstract

Abstract Purpose The aim of this article is to describe a case in which protamine was used for a low-molecular-weight heparin (LMWH) overdose and present an up-to-date review of the literature on the management of LMWH overdose in adults. Summary An unintentional administration of enoxaparin 900 mg occurred in a 73-year-old man with coronavirus disease 2019–related pulmonary embolism. Management of the overdose included a protamine bolus followed by an infusion. Anti–factor Xa levels and activated partial thromboplastin time were monitored. Anti–factor Xa levels declined in a linear fashion irrespective of protamine administration. No bleeding or further thrombotic complications occurred in the patient. A review of the literature revealed that the optimal strategy to treat an LMWH overdose is unknown, with treatment of overdoses ranging from clinical observation to aggressive protamine dosing in reported cases. Although protamine effectively neutralizes unfractionated heparin, it is unable to completely reverse LMWH activity and has variable effects on laboratory measures of LMWH anticoagulant activity. Conclusion The current case report provides additional data to previous literature suggesting that protamine may have a limited effect in decreasing anti–factor Xa levels in LMWH overdose. Continued reporting on the management of LMWH overdoses is warranted to clarify the optimal treatment strategy.